RSS

Brexit

The UK will be leaving the EU on 31 October. This will bring important changes to doing business. Here are five things life science companies can do now to get ready. Read more

News

On the back of opening a new facility in Dundalk, Vincent Dunne, CEO of The Wasdell Group explains some of the challenges of developing a facility in the midst of Brexit and new technologies. Read more

News

The MHRA has reiterated guidance that it has previously given regarding the regulations of medicines if the UK leaves the European Union without a deal. Read more

News

The UK will need to establish its own systems in parallel with that of the European Union for life sciences in the event of a No Deal Brexit, according to a report from the House of Commons Exiting the EU Committee. Read more

News

MedPharmPlast Europe welcomed more than 50 industry experts during a two-day event in Frankfurt. Read more

News

The UK government has announced additional plans to support the transport of medicines in the event of a no deal Brexit. Read more

News

European Pharmaceutical Manufacturer editor Reece Armstrong sits down with Neil Gleghorn, CEO of labelling provider Kallik, to discuss compliance challenges for manufacturers and the threat of counterfeit medicines. Read more

Opinion

Life sciences could have one of the biggest impacts on the UK economy by 2025, bringing in an additional £8.5 billion of growth, according to new research. Read more

News

With the UK bracing itself for Brexit or some other outcome that has not yet been determined, pharma experts discussed the potential effect of Brexit on the supply chain and how to best prepare. Read more

News

Reece Armstrong sits down with Dr Paul Peter Tak, venture partner at Flagship Pioneering and the former senior vice president of R&D, development leader and chief immunology officer at GSK to gain a global perspective on Brexit and pharma. Read more

Opinion

Adam Johnson, director of logistics specialists Tudor International Freight discusses why pharma manufacturers might lose out if the UK leaves the customs union. Read more

News

A major campaign has been launched in Brussels to help attract UK-based pharma and life science business to the Belgian capital following Brexit. Read more

News

Senior professional support lawyer Paul England and Matthew Royle, partner in the life sciences team at international law firm Taylor Wessing discuss what the introduction of a manufacturing waiver to the SPC legislation means for manufacturers. Read more

, Opinion

Rich Quelch, global head of marketing, Origin, looks at how Brexit will affect regulatory bodies in the UK and how this impacts pharmaceutical packagers. Read more

Opinion

Here, editor Reece Armstrong catches up with some of pharma’s leading names to see what else is in store for 2019. Read more

Analysis

Mark Street-Docherty, CEO of Elucigene Diagnostics, explains why the UK’s Industrial Strategy is the shining light amongst the shambles of Brexit. Read more

Opinion

Reece Armstrong examines the looming possibility of a 'no deal' Brexit and why the industry is entering the golden age of innovation. Read more

Opinion

The government is being asked to provide clarity on whether it can guarantee access to medicines and medical products in the event of a ‘no deal’ Brexit. Read more

News

Smaller companies are expected to drive innovation across Europe, according to the latest report from Pharmapack. Read more

News

An extension to Article 50 would benefit pharmaceutical manufacturers trading with Europe, according to an industry logistics expert. Read more

News